Advanced BioMedical Technologies, Inc. Deferred Tax Assets, Valuation Allowance
Advanced BioMedical Technologies, Inc. had Deferred Tax Assets, Valuation Allowance of $797.62 thousand as of 2020-10-31, per its 10-K filed 2021-01-29.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2021-01-29
- 2014-10-31: Deferred Tax Assets, Valuation Allowance 514.33K CNY.
- 2013-10-31: Deferred Tax Assets, Valuation Allowance 484.01K CNY.
CNY
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2014-10-31 | 514.33K CNY 10-K · filed 2015-01-29 |
| 2013-10-31 | 484.01K CNY 10-K · filed 2015-01-29 |
USD
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2020-10-31 | $797.62K 10-K · filed 2021-01-29 | |
| 2019-10-31 | $756.26K 10-K · filed 2021-01-29 | |
| 2018-10-31 | $707.92K 10-K · filed 2020-03-20 | |
| 2017-10-31 | $651.15K 10-K/A · filed 2019-03-29 | $478.79K 10-K · filed 2018-02-13 |
| 2016-10-31 | $442.81K 10-K · filed 2018-02-13 | $602.22K 10-K · filed 2017-02-14 |
| 2015-10-31 | $548.41K 10-K · filed 2017-02-14 | |
| 2014-10-31 | $514.33K 10-K · filed 2016-02-16 | |
| 2012-10-31 | $380.54K 10-K · filed 2013-02-13 | |
| 2011-10-31 | $304.42K 10-K · filed 2013-02-13 |